Development of 225Ac- and 213Bi-labelled somatostatin analogues with improved tumour to kidney ratio for the treatment of neuroendocrine tumours

Institut KU LEUVEN
Phd a commencé le
Phd obtenu le

Mentor

Ooms Maarten

Promoteur

Bormans Guy

Candidat(e)

Ahenkorah Stephen